Status:
COMPLETED
Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Cervical Cancer
Vulvar Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this study is to collect information that may identify people who are at risk of developing lower extremity lymphedema (LEL) after sentinel lymph node biopsy (SLN) during surgery for ea...
Eligibility Criteria
Inclusion
- Presented to MSK with newly diagnosed early-stage cervical cancer of any histologic profile or early stage vulvar cancer of any histologic profile.
- °Early stage: Stage 1-2
- Underwent primary surgery at our institution between January 2006 and January 2022.
- Alive at the time of study activation
- English comprehension
- Capable of providing informed consent
Exclusion
- Had documented macroscopic evidence of metastatic disease at the time of initial diagnosis
Key Trial Info
Start Date :
February 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 19 2025
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT05255393
Start Date
February 15 2022
End Date
November 19 2025
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065